Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coordinated RSV and Influenza Vaccination in Heart Failure
NCT06259487Recruiting
- Sponsor
- Wroclaw Medical University
- Start
- Sep 2023
- Primary completion
- Jun 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of RSV vaccine and influenza vaccine in respiratory syncytial virus infection (RSV) and influenza, sponsored by Wroclaw Medical University. Primary endpoint: All-cause mortality, hospitalization due to heart failure, and clinical signs of infection at 180 days. Started Sep 2023; status: recruiting.
02
Drugs
RSV vaccineinfluenza vaccine
03
Conditions
respiratory syncytial virus infection (RSV)influenza
Beyond the preview
Go deeper on NCT06259487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06259487.